Cefirol-Forte Injection
Cefirol-Forte Injection is a broad-spectrum antibiotic combination of Cefepime, a fourth-generation cephalosporin, and Tazobactam, a beta-lactamase inhibitor. This powerful formulation is designed to effectively combat a wide range of gram-positive, gram-negative, and beta-lactamase-producing bacteria.
Cefepime works by inhibiting bacterial cell wall synthesis, while Tazobactam enhances its efficacy by protecting it from enzymatic degradation. Together, they provide extended antibacterial coverage, making Cefirol-Forte highly effective against severe and resistant infections.
It is commonly indicated for the treatment of respiratory tract infections, urinary tract infections, intra-abdominal infections, skin and soft tissue infections, septicemia, and hospital-acquired infections, especially in critically ill patients. The injection is suitable for IM/IV administration under medical supervision.
Manufactured under strict quality standards, Cefirol-Forte ensures high stability, purity, and consistent therapeutic performance, making it a reliable choice for hospitals and healthcare professionals.
Key Features:
- Cefepime & Tazobactam Injection 2.25 g
- Broad-spectrum antibacterial coverage
- Effective against resistant bacterial strains
- For IM/IV use only
- Ideal for serious and hospital-based infections
Cefirol-Forte Injection stands as a dependable solution for managing complex bacterial infections and improving patient outcomes.
Disclaimer:
This information is for registered medical practitioner only. Anyone other than medical practitioner should consult medical practitioner before using this product.